Interestingly, RNA and MS measurementsconverged at the pathway level, as also shown in a previous study.11 This was especially true for previously characterizedbreast cancer pathways, such as the enrichment of ER responsive genesor immune signaling molecules in ER-positive and ER-negative tumors,respectively. The gene discussed is ESR1; the disease is cancer.